[Federal Register Volume 86, Number 51 (Thursday, March 18, 2021)]
[Notices]
[Pages 14767-14768]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05582]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-809]


Bulk Manufacturer of Controlled Substances Application: Noramco 
Coventry, LLC.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Noramco Coventry, LLC. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 17, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before May 17, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 13, 2021, Noramco Coventry, LLC., 498 
Washington Street, Coventry, Rhode Island 02816, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substances:

------------------------------------------------------------------------
       Controlled substance             Drug code          Schedule
------------------------------------------------------------------------
Marihuana.........................  7360............  I
Tetrahydrocannabinols.............  7370............  I
Dihydromorphine...................  9145............  I
Methylphenidate...................  1724............  II
Oxycodone.........................  9143............  II
Hydromorphone.....................  9150............  II
Hydrocodone.......................  9193............  II
Levorphanol.......................  9220............  II
Morphine..........................  9300............  II
Oripavine.........................  9330............  II
Thebaine..........................  9333............  II
Oxymorphone.......................  9652............  II
Noroxymorphone....................  9668............  II
Tapentadol........................  9780............  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for use as intermediates and converted to other controlled 
substances or for sale to its customers. In reference to drug codes 
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans 
to bulk manufacture these drugs as synthetics. No other

[[Page 14768]]

activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-05582 Filed 3-17-21; 8:45 am]
BILLING CODE P